Search
MacroGenics Inc
MGNXAdd to Watchlist
3.800USD
0.0000.00%
Close 09-24 16:00（ET）
241.53MMarket Cap
LossP/E TTM
MacroGenics Inc (MGNX) Stock Price Target & Forecast
Analyst Rating
Based on 7 analysts giving stock ratings to MacroGenics Inc in the past month.
Buy
1 Strong Buy
2 Buy
4 Hold
0 Sell
0 Strong Sell
Target Price
9.333USD+145.61%
MGNX Analyst Recommendation Trends
In the current month, MGNX has received 2 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. MGNX average Analyst price target in the last month is 9.333.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
1
1
1
1
1
1
1
1
2
2
2
1
1
1
1
1
4
4
4
5
5
5
5
5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7
7
7
7
7
7
7
7
MGNX Analyst Rating for Peer Comparison
Updated: Sep 24, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
1
0
28
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
argenx SE
ARGX
10
13
3
0
0
26
Insmed Inc
INSM
7
17
0
0
0
24
CRISPR Therapeutics AG
CRSP
4
9
11
0
0
24
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Tempus AI Inc
TEM
5
6
7
1
1
20
Financial Forecasting
Based on analysts' estimates, MGNX EPS is projected to reach -0.067 in FY2026Q3, following reported EPS of 0.307 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.29
-0.57
-0.13
-0.07
-0.42
Actual
-0.22
-0.58
0.31
--
--
Surprise
+23.03%
-1.47%
+343.88%
--
--
FAQs
What is MacroGenics Inc's expected revenue for the next quarter?
MacroGenics Inc's expected revenue is 46.40M.
What is MacroGenics Inc's price target?
Analysts forecast that MacroGenics Inc's price target is USD 9.33, with the highest forecast at USD 11.00 and the lowest forecast at USD 6.00.
How have MacroGenics IncMGNX's recent earnings per share performed?
The market expectation was USD 0.31, while MacroGenics IncMGNX's earnings per share (EPS) for the previous quarter was USD -0.58. EPS for the next quarter is expected at USD -0.07.
What is the analyst rating for MacroGenics Inc?
Based on the ratings of MacroGenics Inc's stock from 7 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.